Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary sarcoidosis.

H Nunes1, P Soler, D Valeyre

  • 1Service de Pneumologie, Hôpital Avicenne, GHU Nord, Assistance Publique Hôpitaux de Paris et Faculté de Médecine, Université Paris, Bobigny, France.

Allergy
|April 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Some further insights into oxfendazole broad anthelmintic spectrum: Flukicidal efficacy at a high dose in sheep.

Veterinary parasitology·2026
Same author

Dual Salmonella vaccination attenuates microbiota dysbiosis and enhances microbiota functionality in poultry challenged with S. Typhimurium.

Poultry science·2025
Same author

Axial bone involvement in sarcoidosis has a good prognosis: Longitudinal study of a cohort of 48 patients.

Seminars in arthritis and rheumatism·2025
Same author

Assessment of pathogenic protozoa in a drinking water treatment plant with UV treatment.

Journal of environmental management·2024
Same author

Complete response to mTOR inhibitor following JAKi failure in severe pulmonary sarcoidosis.

Pulmonology·2024
Same author

Low-cost air quality portable sensors and their potential use in respiratory health.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same journal

Deficiency of Mitochondrial Fatty Acid Enzyme, CPT1A, Underlies Airway Epithelial Barrier Dysfunction in Severe Asthma.

Allergy·2026
Same journal

Surgical Management of Non-Allergic Rhinitis-An EAACI Task Force Position Paper.

Allergy·2026
Same journal

Real-World Evaluation of AI-Assisted Readout of Skin Prick Automated Test Results.

Allergy·2026
Same journal

Serotonin Degradation and Lipid Metabolism Regulate Human Tc2 Cell Effector Functions.

Allergy·2026
Same journal

Protein Corona-Coated Crystal Silica From Sandstorms Amplifies Allergic Rhinitis by Regulating Epithelial Integrity in Mice and Human Nasal Epithelia.

Allergy·2026
Same journal

EAACI Guidelines on Environmental Science for Allergy and Asthma-Evidence-Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy.

Allergy·2026
See all related articles

Sarcoidosis is a multisystemic inflammatory disease characterized by granulomas. While often resolving spontaneously, it can lead to chronic conditions like pulmonary fibrosis, impacting multiple organs.

Area of Science:

  • Immunology
  • Pulmonology
  • Rheumatology

Background:

  • Sarcoidosis is a multisystemic disease of unknown cause, marked by immune granuloma formation.
  • It globally affects individuals aged 25-40, with a lifetime incidence of 0.85-2.4%, presenting diverse clinical phenotypes.
  • The lungs and lymphatic system are primarily affected, with genetic susceptibility and environmental factors proposed as triggers.

Purpose of the Study:

  • To provide a comprehensive overview of sarcoidosis, including its etiology, pathogenesis, clinical manifestations, and current management strategies.
  • To highlight the role of specific cytokines in the granulomatous process.
  • To discuss the challenges in long-term management and the need for novel therapeutic approaches.

Main Methods:

  • Review of existing literature on sarcoidosis, focusing on etiology, pathogenesis, clinical presentation, and treatment outcomes.

Related Experiment Videos

  • Analysis of the roles of key cytokines such as Interferon-gamma (IFN-γ), Tumor Necrosis Factor-alpha (TNF-α), Interleukin-12 (IL-12), and Interleukin-18 (IL-18).
  • Evaluation of the efficacy and limitations of current treatments, including corticosteroids and emerging therapies.

    • Main Results:

    • Sarcoidosis pathogenesis involves a complex interplay of genetic predisposition and environmental factors, leading to Th1-mediated granuloma formation.
    • Key cytokines like IFN-γ, TNF-α, IL-12, and IL-18 are critical in driving the inflammatory response.
    • While corticosteroids can manage inflammation, they offer temporary relief and raise concerns about long-term efficacy and side effects.

    Conclusions:

    • Sarcoidosis management requires careful consideration of disease severity and patient tolerance, with corticosteroids indicated for unfavorable cases.
    • Alternative and corticosteroid-sparing therapies are gaining importance for refractory cases.
    • Targeted therapies, including anti-TNF-α agents, are under investigation and show promise for future treatment strategies.